Dynamic changes in pathology and PD‐L1 expression in a patient with metastatic lung adenocarcinoma who received pembrolizumab therapy followed by two salvage surgeries two years later: A case report

Dynamic changes in pathology and PD‐L1 expression in a patient with metastatic lung adenocarcinoma who received pembrolizumab therapy followed by two salvage surgeries two years later: A case report

Abstract During chemotherapy, certain cancer cells undergo cell death, which alters the properties of remaining cells and leads to numerous changes in the constituent cells of lung cancer. Immunotherapy has been used as neoadjuvant therapy, and several studies have reported changes in lung cancer ti...

Full description

Bibliographic Details
Main Authors: Green Hong, Hee Sun Park, Min Kyung Yeo, Dahye Lee, Chaeuk Chung
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Thoracic Cancer
Subjects:
genetic mutations
immunotherapy
lung cancer
PD‐L1
pembrolizumab
salvage surgery
Online Access:https://doi.org/10.1111/1759-7714.15023

Similar Items

Similar Items